Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 6/2020

Open Access 01-06-2020 | Thyroid Cancer | Editorial

Brief progress report from the intersocietal working group on differentiated thyroid cancer

Authors: Frederik A. Verburg, Sukhjeet Ahuja, Anca M. Avram, Manuel Bardiès, Victor Bernet, Patrick Bourguet, Dagmar Führer-Sakel, Ciprian Draganescu, Gilbert H. Daniels, Bennett Greenspan, Seza Gulec, Laszlo Hegedüs, Jacqueline Jonklaas, Markus Luster, Wim Oyen, Johannes Smit, R. Michael Tuttle, Slimane Zerdoud, Douglas Van Nostrand

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 6/2020

Login to get access

Excerpt

In 2017, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, the European Thyroid Association, and the American Thyroid Association established an intersocietal working group on differentiated thyroid cancer (DTC). The mission statement summarizes the purpose, prioritization of discussion topics, and goals of the working group. …
Literature
1.
Tuttle RM, Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, et al. Controversies, consensus and collaboration in the use of I-131 therapy in differentiated thyroid cancer: a joint statement from the American Thyroid Association, the European Society of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. Thyroid. 2019;29:461–70.CrossRef
Metadata
Title
Brief progress report from the intersocietal working group on differentiated thyroid cancer
Authors
Frederik A. Verburg
Sukhjeet Ahuja
Anca M. Avram
Manuel Bardiès
Victor Bernet
Patrick Bourguet
Dagmar Führer-Sakel
Ciprian Draganescu
Gilbert H. Daniels
Bennett Greenspan
Seza Gulec
Laszlo Hegedüs
Jacqueline Jonklaas
Markus Luster
Wim Oyen
Johannes Smit
R. Michael Tuttle
Slimane Zerdoud
Douglas Van Nostrand
Publication date
01-06-2020
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 6/2020
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-020-04744-8

Other articles of this Issue 6/2020

European Journal of Nuclear Medicine and Molecular Imaging 6/2020 Go to the issue

Letter to the Editor

Normalization by bone volume instead of body weight or lean body mass may be better for quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT

Original Article

Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA

Original Article

Role of FDG-PET/CT in children with fever of unknown origin

Editorial

Realising the potential of radioligand therapy: policy solutions for the barriers to implementation across Europe

Correction

Correction to: A new Centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB

Correction

Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA